Masimo | MASI - Ebitda

Aktienkurs
178.63
Täglich Wechseln
-0.08 -0.04%
Monatlich
0.30%
Jährlich
9.09%
Q2 Prognose
174.81




Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
Accuray USD -685K 900K 2024-09
Align Technology USD 183.84M 19.77M 2025-09
AngioDynamics USD 5.94M 3.78M 2025-09
Artivion USD 22.72M 1.84M 2025-12
AtriCure USD 19.86M 2.06M 2025-12
Avanos Medical USD 10M 73.9M 2025-09
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 70.1M 394.2M 2025-12
General Electric Aerospace USD 2.84B 568M 2026-03
Globus Medical USD 280.46M 27.86M 2025-12
Haemonetics USD 115.53M 9.22M 2025-09
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
Masimo USD 91.9M 19.9M 2025-09
Medtronic USD 2.93B 482M 2025-12
Orthofix International USD 27.88M 2.77M 2025-12
Owens Minor USD 90.02M 2.15M 2025-12
ResMed USD 547.48M 27.46M 2025-12
Steris USD 389.7M 22.5M 2025-09
Stryker USD 1.67B 206M 2025-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12